Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.

Rachel S RigoLaura E LevinDonald V BelsitoMaria C GarzonRachelle GandicaKristen M Williams

Published in: Journal of diabetes science and technology (2020)

Skin complications related to CSII or CGM devices are commonly reported in pediatric patients with type 1 diabetes and may lead to interruption or discontinuation of device use. Future studies are needed to elucidate the causes of these reactions and determine the best methods for prevention.

Keyphrases

type diabetes
low dose
current status
risk factors
soft tissue
glycemic control
wound healing
metabolic syndrome
young adults